CNA938 Rewind - 100% tariffs: what US moves mean for Singapore’s pharma sector
Singapore’s pharmaceutical trade and investment prospects – could they take a hit, amid US President Donald Trump’s 100 per cent tariff on branded or patented pharmaceutical products? Daniel Martin speaks with Dr Deborah Elms, Head of Trade Policy at Hinrich Foundation.
Resume
Pause
17 min